Websites using immuno-oncology as a keyword

Driven by our relentless commitment to patients with cancer, NewLink Genetics is at the forefront of immuno-oncology with a unique, multifaceted research strategy using HyperAcute® Cellular Immunotherapies and IDO pathway inhibitor technologies.

Consultation and reviews in the areas of Stem Cell/Marrow Transplantation, Treatment of Acute Lymphoid Leukemias, Oncology Medical Affairs review, Oncology protocol reviews, Use of Bacteriophage for infection treatment and pursuit of non-clinical careers for physicians. stem cell consultations; acute leukemia treatment consultations; autologous transplant consultations; non-clinical jobs for physicians; non-clinical jobs for doctors; searching for non-clinical physician jobs; phage for treating infections; bacteriophage for clinical use; bacteriophage for severe infections; protocol reviews in oncology; protocol reviews in immuno- therapy; protocol re-writing in oncology; protocol research in oncology; protocol research in immuno-therapy; medical affairs reviews: medical reviews of oncology marketing materials; medical reviews of immuno-therapy marketing reviews; scientific reviews for pharmaceutical industry; medical reviews for pharmaceutical industry; scientific review of immuno-therapy; scientific review of oncology marketing materials; first in human protocol reviews; acute leukemias consultations on initial treatment; acute leukemias consultations on resistant disease; acute leukemias consultation on refractory disease; childhood leukemias; pediatric leukemias; T- cell depleted transplants; allogeneic transplant consultation; autologous transplant consultations.

The reference diagnostic company in immuno-oncology.

The reference diagnostic company in immuno-oncology.

ASLAN Pharmaceuticals is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies.

aratinga.bio is a preclinical stage company developing novel immunotherapies to treat both hematological cancers and solid tumors.

Biotechnology start-up dedicated to curing neurodegenerative diseases and cancer.

The Immunotherapy of Cancer Conference (ITOC) is a European meeting which provides a global platform for translational research in immuno-oncology.

癌症已經變了頭號殺手，而我們為您提供有關癌症，癌細胞及癌症治療的全面資訊，包括免疫細胞的抗癌力量。想了解更多, 請即登入網站！

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer.

Consultation and reviews in the areas of Stem Cell/Marrow Transplantation, Treatment of Acute Lymphoid Leukemias, Oncology Medical Affairs review, Oncology protocol reviews, Use of Bacteriophage for infection treatment and pursuit of non-clinical careers for physicians. stem cell consultations; acute leukemia treatment consultations; autologous transplant consultations; non-clinical jobs for physicians; non-clinical jobs for doctors; searching for non-clinical physician jobs; phage for treating infections; bacteriophage for clinical use; bacteriophage for severe infections; protocol reviews in oncology; protocol reviews in immuno- therapy; protocol re-writing in oncology; protocol research in oncology; protocol research in immuno-therapy; medical affairs reviews: medical reviews of oncology marketing materials; medical reviews of immuno-therapy marketing reviews; scientific reviews for pharmaceutical industry; medical reviews for pharmaceutical industry; scientific review of immuno-therapy; scientific review of oncology marketing materials; first in human protocol reviews; acute leukemias consultations on initial treatment; acute leukemias consultations on resistant disease; acute leukemias consultation on refractory disease; childhood leukemias; pediatric leukemias; T- cell depleted transplants; allogeneic transplant consultation; autologous transplant consultations.

Forty Seven, Inc. is committed to the advancement of immuno-oncology through the engagement of new and complementary phagocytic pathways that enhance anti-tumor efficacy and selectivity.

OPDIVO® (nivolumab), for treatment of patients with previously treated locally advanced or metastatic urothelial carcinoma. See Indication and Important Safety Information.

Immunotherapy for cancer with a focus on the tumor the microenvironment is the Issels Immuno-Oncology hallmark. As preeminent specialists in non-toxic immunotherapy and personalized cancer vaccines, we give cancer patients a chance for remission of late stage and resistant cancers.

Find out more about PD-L1 inhibition, CTLA-4 inhibition, other Immuno-Oncology pathways like OX40 agonism, Anti-CEA BiTE, STAT3 inhibition, and PD-1 inhibition.